Viewing Study NCT05914194


Ignite Creation Date: 2025-12-25 @ 1:47 AM
Ignite Modification Date: 2025-12-26 @ 12:05 AM
Study NCT ID: NCT05914194
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-05-21
First Post: 2023-06-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1
Sponsor: NLS Pharmaceutics
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: NLS-1031
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators